Management of multiple sclerosis (MS) occurs in a rapidly changing environment in which decisions must be made using the latest available data and insights. This webinar serves as a review and update to the CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies in Multiple Sclerosis, published in early 2019. These guidelines were developed based on a consensus conference independently convened in 2018 by the Consortium of Multiple Sclerosis Centers (CMSC) among a group of MS experts. As the year 2019 comes to a close, program chairs Corey Ford and Sarah Morrow will review key points of the guideline states, focusing in on current "hot topics" in MS management and that latest updates that arose throughout the year.
Credit Types AAPA: 1.00 ACPE: 1.00 CME: 1.00 CNE: 1.00 CNE - Pharmacology: 1.00 Letter of Completion: 1.00
Release Date: December 2, 2019 Valid for Credit Through: December 31, 2020
0 Yorumlar